CTRI/2022/06/043447尚未招募4 期
Safety, immunogenicity and efficacy after interchangeability of Covid-19 vaccines [Covishield, Covaxin and Sputnik V] among adults in North India: A Randomized Control Trial
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- 未提供
排除标准
- •children less than 18 years
研究者
相似试验
尚未招募
1 期
Safety and Immunological Response following Intradermal COVID-19 vaccination in The Booster (3rd dose)healthy volunteerImmunizationCOVID-19 VaccineIntradermalBooster3rd doseTCTR20211102006Faculty of Medicine Siriraj Hospital, Mahidol University105
Unknown
3 期
BNT162b2 in Thai childreImmunization to prevent COVID-19 infection.COVID-19, vaccination, BNT162b2, children, liver transplant, immunogenicity, safetyTCTR20220708003Chulalongkorn University33
招募中
3 期
Safety, humoral and cellular immunogenicity after coronavirus disease-19 (COVID-19) vaccination (BNT162b2) in 12 to 18 year-old children after liver transplantatioImmunization to prevent COVID-19 infectionCOVID-19, vaccination, BNT162b2, adolescent, liver transplant, immunogenicity, safetyTCTR20210830002Chulalongkorn university44
尚未招募
1 期
Safety, preliminary efficacy and immunogenicity of traditional Chinese medicine miRNA hydrogel in the treatment of eczema: a randomized, double-blind, placebo-controlled, dose-increasing clinical studyeczemaITMCTR2000003604Shanghai Skin Disease Hospital
尚未招募
不适用
Investigate the safety and efficacy of small cell lung cancer,Kidney cancer and Primary liver cancer immunotherapyHistopathologically confirmed small cell lung cancer (SCLC)Histopathologically confirmed Kidney cancerHistopathologically confirmed Liver cancerACTRN12618001337268The First Teaching Hospital, Inner Mongolia Medical University50